top of page

Home
Bio
Meet the team
Recent Publications
Contact
More

Use tab to navigate through the menu items.

Welcome to

The gupta
Onconephrology research lab at BWH/DFCI

A shorter duration of corticosteroids (28 days or less) may be safe for patients with ICPi-AKI.

Figure 1 Steroid Paper.jpg

Shruti Gupta, MD, MPH

An Assistant Professor of Medicine at Harvard Medical School and Director of Onconephrology in the Division of Renal Medicine at Brigham and Women’s Hospital. She uses epidemiologic, translational, genetic, and interventional studies to address novel and clinically important questions in acute kidney injury and critical illness related to cancer. Read full biography.

Harvard_Medical_School_shield.svg.png

Featured Publications and Awards

- Shorter versus Longer Corticosteroid Duration and Recurrent Immune Checkpoint Inhibitor-Associated AKI. Journal for Immunotherapy of Cancer 2022

- Acute Kidney Injury in Patients Receiving Pembrolizumab Combination Therapy versus Pembrolizumab Monotherapy for Advanced Lung Cancer. Kidney International 2022

- Acute Kidney Injury in Critically Ill Patients with Cancer. Clinical Journal of the American Society of Nephorology 2022

Best Clinical/Translational Cancer Immunotherapy Paper
SITC 2022

Chair’s Research Award
2022 BWH

bottom of page